Advertisement

Enzyme Therapy in Chronic Pancreatitis

  • P. Layer
  • J. Keller

Abstract

A typical feature of chronic pancreatitis is progressive impairment of pancreatic enzyme output with resulting maldigestion of macronutrients. It has been demonstrated by us and others that in chronic pancreatitis of alcoholic aetiology, most patients devolop malabsorption in the second decade following the first onset of symptoms, although more rapid courses occur (1,2,3). In chronic pancreatitis of idiopathic origin, the mean latency between onset of symptomatic disease and pancreatic insufficiency is 20 to 30 years (3).

Keywords

Chronic Pancreatitis Pancreatic Enzyme Pancreatic Lipase Pancreatic Insufficiency Pancreatic Exocrine Insufficiency 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    DiMagno EP, Malagelada JR, Go VLW (1975) Relationship between alcoholism and pancreatic insufficiency. NY Acad Sei 252:200–207.CrossRefGoogle Scholar
  2. 2.
    DiMagno EP, Layer P (1993) Human exocrine pancreatic enzyme secretion. In: Go VLW et al. (eds): The pancreas: biology, pathobiology, and diseases, 2nd edn. Raven Press, New York, pp 275–300.Google Scholar
  3. 3.
    Layer P, Yamamoto H, Kalthoff L, Ciain JE, Bakken LJ, DiMagno EP (1994) The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 107:1481–1487.PubMedGoogle Scholar
  4. 4.
    DiMagno EP, Go VLW, Summerskill WHJ (1973) Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815.PubMedCrossRefGoogle Scholar
  5. 5.
    DiMagno EP, Ciain JE, Layer P (1993) Chronic pancreatitis. In: Go VLW et al. (eds): The pancreas: biology, pathobiology, and diseases, 2nd edn. Raven Press, New York, pp 665–706.Google Scholar
  6. 6.
    Layer P, Zinsmeister AR, DiMagno EP (1986) Effects of decreasing intraluminal amylase activity on starch digestion and postprandial gastrointestinal function in humans. Gastroenterology 91:41–48.PubMedGoogle Scholar
  7. 7.
    Layer P, Go VLW, DiMagno EP (1986) Fate of pancreatic enzymes during aboral small intestinal transit in humans. Am J Physiol 251: G475-G480.PubMedGoogle Scholar
  8. 8.
    Keller J, Rünzi M, Goebell H, Layer P (1997) Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol 272: G632–G637.PubMedGoogle Scholar
  9. 9.
    Layer P, von der Ohe MR, Holst JJ et al. (1997) Altered postprandial motility in chronic pancreatitis: role of malabsorption. Gastroenterology 112:1624–1634.PubMedCrossRefGoogle Scholar
  10. 10.
    Sternby B, Holtmann G, Kelly DG, DiMagno EP (1990) Effect of gastric or duodenal nutrient infusion on gastric and pancreatic lipase secretion. Gastroenterology 102: A292Google Scholar
  11. 11.
    Hamosh M (1990) Lingual and gastric lipases. Nutrition 6:421–428.PubMedGoogle Scholar
  12. 12.
    Gargouri Y, Pieroni G, Riviere C et al. (1986) Importance of human gastric lipase for intestinal lipolysis: an in vitro study. Biochem Biophys Acta 879:419–423.PubMedGoogle Scholar
  13. 13.
    Layer P, Holtmann G (1994) Pancreatic enzymes in chronic pancreatitis (state-of-the-art). Int J Pancreatol 15:1–11.PubMedGoogle Scholar
  14. 14.
    Carriere F, Barrowman JA, Verger R, Laugier R (1993) Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 105:876–888.PubMedGoogle Scholar
  15. 15.
    Layer P, Baumann J, Hellmann C, von der Ohe M, Gröger G, Goebell H (1990) Effect of luminal protease inhibition on prandial nutrient digestion during small intestinal chyme transit. Pancreas 5:718.Google Scholar
  16. 16.
    DiMagno EP, Malagelada JR, Go VLW, Moertel CG (1977) Fate of orally ingested enzymes in pancreatic insufficiency: comparison of two dosage schedules. N Engl J Med 296:1318–1322.PubMedCrossRefGoogle Scholar
  17. 17.
    Layer P, Jansen JBMJ, Cherian L, Lamers CBHW, Goebell H (1990) Feedback regulation of human pancreatic secretion: effects of protease inhibition on duodenal delivery and small intestinal transit of pancreatic enzymes. Gastroenterology 98:1311–1319.PubMedGoogle Scholar
  18. 18.
    Kelly DG, Sternby B, DiMagno EP (1991) How to protect human pancreatic enzyme activities in frozen duodenal juice. Gastroenterology 100:189–195.PubMedGoogle Scholar
  19. 19.
    Holtmann G, Kelly DG, Sandberg RJ, Bentley KJ, Magocsi L, DiMagno EP (1991) Is the survival of human lipolytic activity (LA) during aboral transit affected by the amount of calories, nutrient, chymotrypsin (CT) or bile acid (BA) entering the duodenum? Gastroenterology 100: A276.Google Scholar
  20. 20.
    Granger M, Abadie B, Marchis-Mouren G (1975) Limited action of trypsin on porcine pancreatic amylase: characterization of the fragments. FEBS Lett 56:189–193.PubMedCrossRefGoogle Scholar
  21. 21.
    Thiruvengadam R, DiMagno EP (1988) Inactivation of human lipase by proteases. Am J Physiol 255: G476–481.PubMedGoogle Scholar
  22. 22.
    Layer P, Hellmann C, Baumann J, von der Ohe M, Gröger G, Goebell H (1990) Modulation of physiologic fat malabsorption in humans. Digestion 46:153.Google Scholar
  23. 23.
    Layer P, von der Ohe M, Gröger G, Dicke D, Goebell H (1992) Luminal availability and digestive efficacy of substituted enzymes in pancreatic insufficiency. Pancreas 7:745Google Scholar
  24. 24.
    Stephen AM, Haddad AC, Phillips SF (1983) Passage of carbohydrate into the colon. Gastroenterology 85:589–595.PubMedGoogle Scholar
  25. 25.
    Levitt MD, Hirsh P, Fetzer CA, Sheahan M, Levine AS (1987) H2 excretion after ingestion of complex carbohydrates. Gastroenterology 92:383–389.PubMedGoogle Scholar
  26. 26.
    Layer P, Peschel S, Schlesinger T, Goebell H (1990) Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol 258: G196–G201.PubMedGoogle Scholar
  27. 27.
    Jain NK, Boivin M, Zinsmeister AR, DiMagno EP (1991) The ileum and carbohydrate mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans. Pancreas 6:495–505.PubMedCrossRefGoogle Scholar
  28. 28.
    Layer P, Schlesinger T, Goebell H (1993) Modulation of periodic interdigestive gastrointestinal motor and pancreatic function by the ileum. Pancreas 8:426–432.PubMedCrossRefGoogle Scholar
  29. 29.
    Read NW, McFarlane A, Kinsman RJ et al. (1984) Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 86:274–280.PubMedGoogle Scholar
  30. 30.
    Spiller RC, Trotman IF, Higgins BE et al. (1984) The ileal brake: inhibition of jejunal motility after ileal fat perfusion in man. Gut 25:365–374.PubMedCrossRefGoogle Scholar
  31. 31.
    Jain NK, Boivin M, Zinsmeister AR, Brown ML, Malagelada JR, DiMagno EP (1989) Effect of perfusing carbohydrates and amylase inhibitor into the ileum on gastrointestinal hormones and gastric emptying of homogenized meal. Gastroenterology 96:377–387.PubMedGoogle Scholar
  32. 32.
    Layer P, Holst JJ, Grandt D, Goebell H (1995) Ileal release of glucagon-like-1 peptide (GLP-1): association with inhibition of gastric acid secretion in humans. Dig Dis Sei 40:1074–1082.CrossRefGoogle Scholar
  33. 33.
    Layer P, von der Ohe M, Gröger G, Grandt D, Rünzi M, Goebell H (1995) Late postprandial motility changes in chronic pancreatitis: pathogenetic role of malabsorption. Gastroenterology 108: A368.CrossRefGoogle Scholar
  34. 34.
    Regan PT, Malagelada JR, DiMagno EP, Glanzman SL, Go VLW (1977) Comparative effects of antacids, Cimetidine, and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. N Engl J Med 297:854–858.PubMedCrossRefGoogle Scholar
  35. 35.
    Layer P, Ohe MR, Grandt D et al. (1997) Altered postprandial motility in chronic pancreatitis: role of malabsorption. Gastroenterology (in press).Google Scholar
  36. 36.
    Heizer WD, Cleaveland CR, Iber FL (1965) Gastric inactivation of pancreatic supplements. Bull Johns Hopkins Hosp 116:261–270.PubMedGoogle Scholar
  37. 37.
    Carroccio A, Pardo F, Montalto G et al. (1992) Use of famotidine in severe exocrine pancreatic insufficiency with persistent maldigestion on enzymatic replacement therapy. Dig Dis Sei 37:1441–1446.CrossRefGoogle Scholar
  38. 38.
    Heijerman HG, Lamers CB, Bakker W (1991) Omeprazole enhances the efficacy of pancreatin (pancrease) in cystic fibrosis. Ann Intern Med 114:200–210.PubMedGoogle Scholar
  39. 39.
    Goebell H, Klotz U, Nehlsen B, Layer P (1993) Oroileal transit of slow release 5-ASA. Gut 34:669–675.PubMedCrossRefGoogle Scholar
  40. 40.
    Code CF, Schlegel JF (1973) The gastrointestinal interdigestive housekeeper: motor correlates of the interdigestive myoelectric complex of the dog. In: Daniel EE (ed) Proc 4th Int Symp on GI Motility. Mitchell Press, Vancouver, pp 631–634.Google Scholar
  41. 41.
    Schlegel JF, Code CF (1975) The gastric peristalsis of the interdigestive housekeeper. In: Vantrappen G (ed) Proc 5th Int Symp on GI Motility. Typoff Press, Leuven, pp 321.Google Scholar
  42. 42.
    Layer P, Gröger G, Dicke D, von der Ohe M, Goebell H (1992) Enzyme pellet size and luminal nutrient digestion in pancreatic insufficiency. Digestion 52:100.Google Scholar
  43. 43.
    Meyer JH, Ohashi H, Jehn D, Thomson JB (1981) Size of liver particles emptied from the human stomach. Gastroenterology 80:1489–1496PubMedGoogle Scholar
  44. 44.
    Meyer JH, Elashoff J, Porter-Fink V, Dressman J, Amidon GL (1988) Human postprandial gastric emptying of 1–3-millimeter spheres. Gastroenterology 94:1315–1325.PubMedGoogle Scholar
  45. 45.
    Kölbel C, Layer P, Hotz J, Goebell H (1986) Der Einfluss eines säuregeschützten, mikroverkapselten Pankreatinpräparats auf die pankreatogene Steatorrhö. Med Klin 81:85–86.Google Scholar
  46. 46.
    Lankisch PG, Lembcke B, Göke B, Creutzfeldt W (1983) Therapie der pankreatogenen Steatorrheo: Bietet der Säureschutz für Pankreasenzyme Vorteile? Verh Dtsch Ges Inn Med 89:864–867.Google Scholar
  47. 47.
    Dutta SK, Rubin J, Harvey J (1983) Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency. Gastroenterology 84:476–482.PubMedGoogle Scholar
  48. 48.
    Hendeles L, Dorf A, Stecenko A, Weinberger M (1990) Treatment failure after substitution of generic pancrelipase capsules. Correlation with in vitro lipase activity. JAMA 263:2459–2461.PubMedCrossRefGoogle Scholar
  49. 49.
    Caliari S, Benini L, Sembenini C, Gregori B, Carnielli V, Vantini I (1996) Medium-chain triglyceride absorption in patients with pancreatic insufficiency. Scand J Gastroenterol 31:90–94.PubMedCrossRefGoogle Scholar
  50. 50.
    FitzSimmons SC, Burkhart GA, Borowitz D et al. (1997) High-dose pancreatic enzyme supplements and fibrising colonopathy in children with cystic fibrosis. N Engl J Med 336:1283–1289.PubMedCrossRefGoogle Scholar
  51. 51.
    MacSweeney EJ, Oades PJ, Buchdahl R, Rosenthal M, Bush A (1995) Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet 345:752–756.CrossRefGoogle Scholar
  52. 52.
    Ihse I, Lilja P, Lundquist I (1977) Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in man. Digestion 15:303–308.PubMedCrossRefGoogle Scholar
  53. 53.
    Krawisz BR, Miller LJ, DiMagno EP, Go VLW (1980) In the absence of nutrient pancreatic-biliary secretions in the jejunum do not exert feedback control of human pancreatic or gastric function. J Lab Clin Med 95:13–18.PubMedGoogle Scholar
  54. 54.
    Hotz J, Ho SB, Go VLW, DiMagno EP (1983) Short-term inhibition of duodenal tryptic activity does not affect human pancreatic, biliary or gastric function. J Lab Clin Med 101:488–495.PubMedGoogle Scholar
  55. 55.
    Slaff J, Jacobson D, Tillmann CR, Curington C, Toskes PP (1984) Protease-specific suppression of pancreatic exocrine secretion. Gastroenterology 87:44–52.PubMedGoogle Scholar
  56. 56.
    Owyang C, Louie DS, Tatus D (1986) Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. J Clin Invest 77:2042–2047.PubMedCrossRefGoogle Scholar
  57. 57.
    Owyang C, May D, Louie DS (1986) Trypsin suppression of pancreatic enzyme secretion. Differential effect on cholecystokinin release and the enteropancreatic reflex. Gastroenterology 91:637–643.PubMedGoogle Scholar
  58. 58.
    Adler G, Reinshagen M, Koop I et al. (1989) Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion. Gastroenterology 96:1158–1164.PubMedGoogle Scholar
  59. 59.
    Mössner J, Stange JH, Ewald M, Kestel W, Fischbach W (1991) Influence of exogenous application of pancreatic extract on endogenous pancreatic enzyme secretion. Pancreas 6:637–644.PubMedCrossRefGoogle Scholar
  60. 60.
    Mössner J, Wresky HP, Kestel W, Zeeh J, Regner U, Fischbach W (1989) Influence of treatment with pancreatic extracts on pancreatic enzyme secretion. Gut 30:1143–1149.PubMedCrossRefGoogle Scholar
  61. 61.
    Isaksson F, Ihse I (1983) Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sei 28:97–102.CrossRefGoogle Scholar
  62. 62.
    Halgreen H, Thorsgaard Pedersen N, Worning H (1986) Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroenterol 21:104–108.PubMedCrossRefGoogle Scholar
  63. 63.
    Mössner J, Secknus R, Meyer J, Niederau C, Adler G (1992) Treatment of pain with pancreatic extracts in chronic pancreatitis: results of a prospective placebo-controlled multicenter trial. Digestion 53:54–66.PubMedCrossRefGoogle Scholar
  64. 64.
    Kühnelt P, Mundlos S, Adler G (1991) Einfluss der Pelletgrösse eines Pankreasenzympräparates auf die duodenale lipolytische Aktivität. Z Gastroenterol 29:417–421.PubMedGoogle Scholar
  65. 65.
    Layer P, von der Ohe M, Gröger G, Cherian L, Rolle K, Goebell H (1992) Intraluminal proteolytic degradation of lipase and fat malabsorption in pancreatin-treated pancreatic insufficiency. Pancreas 7:745.Google Scholar
  66. 66.
    Zentler Munro PL, Assoufi BA, Balasubramanian K et al. (1992) Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis. Pancreas 7:311–319.PubMedCrossRefGoogle Scholar
  67. 67.
    Schneider MU, Knoll-Ruzicka ML, Domschke S, Heptner G, Domschke W (1985) Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated micro-spheric pancreatin and acid-stable fungal enzyme preparations on steatorrhea in chronic pancreatitis. Hepatogastroenterology 32:97–102.PubMedGoogle Scholar
  68. 68.
    Griffin SM, Alderson D, Farndon JR (1989) Acid resistant lipse as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs. Gut 30:1012–1015.PubMedCrossRefGoogle Scholar
  69. 69.
    Moreau J, Bousson M, Saint Marc Girardin MF, Pignal F, Bommelaer G, Ribet A (1988) Comparison of fungal lipase and pancreatic lipase in exocrine pancreatic insufficiency in man. Study of their in vitro properties and intraduodenal bioavailability. Gastroenterol Clin Biol 12:787–792.PubMedGoogle Scholar
  70. 70.
    Carriere F, Barrowman JA, Verger R, Laugier R (1993) Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. Gastroenterology 105:876–888.PubMedGoogle Scholar
  71. 71.
    Abrams CK, Hamosh M, Dutta SK, Hubbard VS, Hamosh P (1987) Role of nonpancreatic lipolytic activity in exocrine pancreatic insufficiency. Gastroenterology 92:125–129.PubMedGoogle Scholar
  72. 72.
    Balasubramanian K, Zentler Munro PL, Batten JC, Northfield TC (1992) Increased intragastric acid-resistant lipase activity and lipolysis in pancreatic steatorrhoea due to cystic fibrosis. Pancreas 7:305–310.PubMedCrossRefGoogle Scholar
  73. 73.
    Borel P, Armand M, Senft M, Andre M, Lafont H, Lairon D (1991) Gastric lipase: evidence of an adaptive response to dietary fat in the rabbit. Gastroenterology 100:1582–1589.PubMedGoogle Scholar
  74. 74.
    Bodmer MW, Angal S, Yarranton GT et al. (1987) Molecular cloning of a human gastric lipase and expression of the enzyme in yeast. Biochim Biophys Acta 909:237–244.PubMedGoogle Scholar
  75. 75.
    Suzuki A, Mizomutu A, Metzger A, Rerknimitr R, Sarr MG, DiMagno EP (1996) Can small amounts of lipolytic activity correct pancreatic steatorrhea and is this related to diet? Gastroenterology 110: A433.Google Scholar
  76. 76.
    Maeda H, Danel C, Crystal RG (1994) Adenovirus-mediated transfer of human lipase complementary DNA to the gallbladder. Gastroenterology 107:231–235.Google Scholar

Copyright information

© Springer-Verlag London Limited 1999

Authors and Affiliations

  • P. Layer
  • J. Keller

There are no affiliations available

Personalised recommendations